TCT Meetings, February 8-12, 2021
Join Omixon on this virtual conference Online, on February 8-12! Read more about the conference HERE.
Omnitype
Omixon Launches OmniType, Multiplex For NGS-based HLA Genotyping
Omixon proudly announces the launch of OmniType, a 11-locus multiplex human leukocyte antigen (HLA) genotyping assay and software product for use on the Illumina® sequencing platforms (such as MiSeq, MiniSeq and iSeq). OmniType offers a revolutionary single working-day workflow that allows processing of samples from gDNA to a ready-to-sequence...
Omixon Founder, Attila Bérces Returns as CEO, Aims to Roll-Out New Products
We are happy to announce that Omixon’s founder and chairman Dr. Attila Bérces returns as CEO. Outgoing CEO Dr. Peter Meintjes led the early commercialization of Omixon’s flagship product Holotype HLA since 2014 before stepping into the CEO role in 2017. In concert between the incoming and outgoing CEOs,...
All Russian Conference, March 12-13, 2020
Join Omixon for our talk at the Registries of Bone Marrow Donors: Today and Tomorrow conference in Moscow, Russia on March 12! Read more about our talk here.
“High Throughput HLA Typing Approaches Using NGS” – Omixon Talk in Moscow
Join Omixon for our talk at the Registries of Bone Marrow Donors: Today and Tomorrow conference in Moscow, Russia on March 12! The talk will be presented by Nina Lauterbach, PhD, Senior Field Application Scientist at Omixon. Date: Thursday, March 12, 2020 Venue: Center for the Development of Charity...
